| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 05/26/2006 | CA2572302A1 Treatment of neuropathic pain, fibromyalgia or rheumatoid arthritis |
| 05/26/2006 | CA2528191A1 Novel formulation of pyridoxal 5'-phosphate and method of preparation |
| 05/26/2006 | CA2527875A1 Adapalene polymorphic forms |
| 05/26/2006 | CA2488463A1 Creatine composition and use |
| 05/25/2006 | WO2006045119A9 Improved inhibitors for the soluble epoxide hydrolase |
| 05/25/2006 | WO2006029577A9 Methods and compositions for the treatment of hyperlipidemia |
| 05/25/2006 | US20060111585 Title of the invention n-cyclohexylaminocarbonyl benzensulfonmide derivatives |
| 05/25/2006 | US20060111569 Thiazolopyrimidines and their use as modulators of chemokine receptor activity |
| 05/25/2006 | US20060111567 Nonpeptide substituted spirobenzoazepines as vasopressin antagonists |
| 05/25/2006 | US20060111556 Preventives/remedies for neurodegenerative diseases |
| 05/25/2006 | US20060111553 Novel thrombin inhibitors, the preparation and use thereof |
| 05/25/2006 | US20060111451 1-Chloro-2,4-dinitrobenzene gel compositions and methods for using the same |
| 05/25/2006 | US20060111450 Compositions and methods for treating alzheimer's disease and related disorders and promoting a healthy nervous system |
| 05/25/2006 | US20060111449 Use of long-chain alcohols for effectively lowering elevated cholesterol levels |
| 05/25/2006 | US20060111448 Methods for treating cognitive impairment in humans with multiple sclerosis |
| 05/25/2006 | US20060111447 Inhibiting progressive cognitive impairment |
| 05/25/2006 | US20060111446 5-Amidino-N-(2-aminophenethyl)-2-hydroxybenzenesulfonamide derivative, medicinal composition containing the same, pharmaceutical use thereof, and intermediate therefor |
| 05/25/2006 | US20060111445 Novel carboxylic acids and derivatives for the treatment of and preventing diabetes and dyslipidaemia |
| 05/25/2006 | US20060111444 Novel halogen-substituted aminodicarboxylic acid derivatives |
| 05/25/2006 | US20060111443 Preventive therapeutic composition for muscular fatigue, pulled muscle and disease attributed thereto |
| 05/25/2006 | US20060111442 Use of methyl pyruvate to increase cellular energy production downstream of glycolysis for the PARP-1 ablation of HIV without necrotic cell death caused by continuous, chronic PARP-1 activation through the concomitant depletion of ATP and NAD. |
| 05/25/2006 | US20060111441 Injections, oral or subcutaneous drug delivery of N-(3-trifluoromethyl-4-cyano)phenyl-2-hydroxy-2-methyl-3-(4-cyano)phenoxy propamide; muscular, genetic, nervous system, skin, respiratory system, urogenital, metabolic disorders; anticarcinogenic agents |
| 05/25/2006 | US20060111440 Cathepsin cysteine protease inhibitors |
| 05/25/2006 | US20060111439 Acyloxyalkyl carbamate prodrugs of sulfinic acids, methods of synthesis, and use |
| 05/25/2006 | US20060111438 Asymmetric synthesis of substituted dihydrobenzofurans |
| 05/25/2006 | US20060111437 Hyperlipemia therapeutic agent |
| 05/25/2006 | US20060111436 Compositions and treatments for modulating kinase and/or HMG-CoA reductase |
| 05/25/2006 | US20060111435 Compositions for treating or preventing obesity and insulin resistance disorders |
| 05/25/2006 | US20060111434 Method for preparing derivatives of fungicidal iodochromones |
| 05/25/2006 | US20060111433 Administering bergapten; modulate the expression of genes for gamma-globin in the human cell line K562; genetic blood disorders |
| 05/25/2006 | US20060111432 Paclitaxel dissolved in polyoxyethylated castor oil and alcohol and stabilized with carbon dioxide to bring the pH of the solution to about 5; suitable for use in treating patients with breast cancer, ovarian cancer, lung cancer, melanoma, and lymphoma |
| 05/25/2006 | US20060111431 Thiophene carboxanmides as inhibitors of the enzyme ikk-2 |
| 05/25/2006 | US20060111430 2,3,4-substituted cyclopentanones as therapeutic agents |
| 05/25/2006 | US20060111429 Novel compounds |
| 05/25/2006 | US20060111428 Combination of an dpp-iv inhibitor and a ppar-alpha compound |
| 05/25/2006 | US20060111427 Indole derivatives useful as progesterone receptor modulators |
| 05/25/2006 | US20060111426 Indole-3-sulphur derivaties |
| 05/25/2006 | US20060111425 To treat diseases of respiratory, urinary and gastrointestinal systems; highly selective; significant potency; (2R,2S)(1 alpha ,5 alpha ,6 alpha )-N-{-[4-(1,3-dioxo-1,3-dihydro-isoindol-2-yl)-butyl]-3-azabicyclo[3.1.0]hex-6-yl-methyl}-2-hydroxy-2-cyclopentyl-2-phenylacetamide |
| 05/25/2006 | US20060111424 Treating nuclear hormone receptor-associated conditions such as cancer and immune disorders; (3a alpha ,4 alpha ,7 alpha ,7a alpha )-2-(3-Chloro-4-hydroxyphenyl)hexahydro-4,7-methano-1H-isoindole-1,3(2H)-dione |
| 05/25/2006 | US20060111423 Use of diindolylmethane-related indoles and growth factor receptor inhibitors for the treatment of human cytomegalovirus-associated disease |
| 05/25/2006 | US20060111422 hypocholesterolemic and hypolipidemic agents; hypertriglyceridemia, atherosclerosis, Alzheimer's Disease, benign prostatic hypertrophy (BPH), diabetes and osteoporosis; (3R, 5R)-7-[2-(4-fluoro-phenyl)-4-isopropyl-5-(4-methyl-benzylcarbamoyl)-2H-pyrazol-3-yl]-3,5-dihydroxy-heptanoic acid |
| 05/25/2006 | US20060111421 Administering a dihydrophenanthridinylbenzenesulfonamide or a substituted 4-(1H or 2H-indazol-3-yl)phenol; interaction with estrogen receptor ER-alpha and/or -beta with no creatine kinase stimulation and without uterotropic activity |
| 05/25/2006 | US20060111420 Sorbicillactone-a derivatives for the treatment of tumour and viral diseases |
| 05/25/2006 | US20060111419 Novel fused indazole compounds |
| 05/25/2006 | US20060111418 Blood-brain barrier disruption inhibitor |
| 05/25/2006 | US20060111417 Amorphous telmisartan |
| 05/25/2006 | US20060111416 Octahydropyrrolo[3,4-C]pyrrole derivatives |
| 05/25/2006 | US20060111415 2-Aminonaphthalene derivatives and related glycogen phosphorylase inhibitors |
| 05/25/2006 | US20060111414 2-Amino-1-functionalized tetralin derivatives and related glycogen phosphorylase inhibitors |
| 05/25/2006 | US20060111413 2-Amino-3-functionalized tetralin derivatives and related glycogen phosphorylase inhibitors |
| 05/25/2006 | US20060111412 Substituted 5-oxo pyrazoles and [1,2,4]triazoles as antiviral agents |
| 05/25/2006 | US20060111411 Substituted 5-carboxyamide pyrazoles and [1,2,4]triazoles as antiviral agents |
| 05/25/2006 | US20060111409 Medicament for treatment of diabetes |
| 05/25/2006 | US20060111408 Therapeutic benzothiazole compounds |
| 05/25/2006 | US20060111407 Association between a heterocyclic compound stimulating lipid and carbohydrate metabolisms and an antioxidant agent for treating obesity |
| 05/25/2006 | US20060111406 Amide linker peroxisome proliferator activated receptor modulators |
| 05/25/2006 | US20060111405 Such as 5,6-diphenylamino-2,3-pyridindione; cyclooxygenase selective inhibitors; antiinflammatory agents |
| 05/25/2006 | US20060111404 Salts of N-[2-({(3R)-1-[trans-4-hydroxy-4-(6-methoxypyridin-3-yl)-cyclohexyl]pyrrolidin-3-yl}amino)-2-oxoethyl]-3-(trifluoromethyl)benzamide |
| 05/25/2006 | US20060111402 Novel benzimidazole derivatives useful as selective androgen receptor modulators (SARMS) |
| 05/25/2006 | US20060111401 Taxanes having a C10 carbonate substituent |
| 05/25/2006 | US20060111400 Piperidinetriol derivatives as inhibitors of glycosylceramidsynthase |
| 05/25/2006 | US20060111399 Salts of N-(4-fluorobenzyl)-N-(1-methylpiperidin-4-yl)-N'-(4-(2-methylpropyloxy)phenylmethyl)carbamide and their preparation |
| 05/25/2006 | US20060111398 Therapeutic use of farnesyltransferase inhibitors and methods of monitoring the efficacy thereof |
| 05/25/2006 | US20060111397 Methods and compositions for treating diseases associated with excesses in ACE |
| 05/25/2006 | US20060111396 4-Phenyl substituted tetrahydroisoquinolines and use thereof to block reuptake of norepinephrine, dopamine and serotonin |
| 05/25/2006 | US20060111395 Aryl-and heteroaryl-substituted tetrahydroisoquinolines and use thereof to block reuptake of norepinephrine, dopamine and serotonin |
| 05/25/2006 | US20060111394 Aryl-and heteroaryl-substituted tetrahydroisoquinolines and use thereof to block reuptake of norepinephrine, dopamine and serotonin |
| 05/25/2006 | US20060111393 4-Phenyl substituted tetrahydroisoquinolines and use thereof to block reuptake of norepinephrine, dopamine and serotonin |
| 05/25/2006 | US20060111392 Substituted biaryl-carboxylate derivatives |
| 05/25/2006 | US20060111391 6-(3-nitro-phenyl)-3,3-spiro[cyclohexane]-imidazo[1,2-a]pyridin-2-one; depletion of estrogen, osteopenia, osteoporosis; hormone sensitive cancers, hyperplasia of the breast, endometrium, cervix and prostate; endometriosis, uterine fibroids |
| 05/25/2006 | US20060111390 Azaindoles as inhibitors of c-jun n-terminal kinases |
| 05/25/2006 | US20060111389 Therapeutic acridone and acridine compounds |
| 05/25/2006 | US20060111388 Phenanthroline and derivatives thereof used to lower intraocular pressure in an affected eye |
| 05/25/2006 | US20060111387 Immonomoderators; viricides; anticancer agents; for example, 2-Butyl-1-isobutyl-7-(thiophen-3-yl)-1H-imidazo[4,5-c]quinolin-4-amine; use of these compounds for inducing or inhibiting cytokine biosynthesis in animals |
| 05/25/2006 | US20060111386 Novel 4-phenyl substituted tetrahydroisoquinolines and therapeutic use thereof |
| 05/25/2006 | US20060111385 Novel 4-phenyl substituted tetrahydroisoquinolines and therapeutic use thereof |
| 05/25/2006 | US20060111384 containing carboxamide or thiocarboxamide at the 3-position are useful as analgesics, antidiarrheal agents, anticonvulsants, antitussives and antiaddiction drugs; affinity for the opioid receptor |
| 05/25/2006 | US20060111383 Preparing a mixture comprising oxycodone and a solvent, adjusting the pH of the mixture to less than 6 and heating the mixture at the temperature of at least 55 degrees C for a period of at least 1 hour; and subsequently; exposing the mixture to hydrogenation reagents |
| 05/25/2006 | US20060111382 Compositions and methods for treating or preventing pain |
| 05/25/2006 | US20060111381 Amidine compounds |
| 05/25/2006 | US20060111380 4-(2-naphtyl)-2-[3-oxospiro[isobenzofuran-1 (3H), 4'-piperidin]-1'-yl]-1H-imidazole, 4-(4-bromophenyl)-2-[3-oxospiro[isobenzofuran-1(3H),4'-piperidin]-1-yl]-1H imidazole; metabolic, genitalor reproductive, gastro-intestinal, respiratory system disorders, antiinflammatory agent or glaucoma; cyclization |
| 05/25/2006 | US20060111379 Salt of 4-[[4-[[4-(2-cyanoethenyl)-2,6-dimethylphenyl]amino]-2-pyrimidinyl]amino] benzonitrile |
| 05/25/2006 | US20060111378 Substituted 2-anilinopyrimidines as cell-cycle-kinase or receptor-tyrosine-kinase inhibitors, their production and use as pharmaceutical agents |
| 05/25/2006 | US20060111377 Heterocyclic derivatives |
| 05/25/2006 | US20060111376 2,4-Diamino quinazoline and pyridopyrimidine ester derivatives as dihydrofolate reductase inhibitors |
| 05/25/2006 | US20060111375 Compound having tgfß inhibitory activity and medicinal composition containing the same |
| 05/25/2006 | US20060111374 N-(3-amino-propyl)-N-[1-(3-benzyl-4-oxo-3,4-dihydro-pyrido[2,3-d]pyrimidin-2-yl)-2-methyl-propyl]-4-methyl-benzamide; kinesin spindle protein inhibitor; cell division, mitosis phase arrest; antiproliferative and antiinflammation agent, hyperplasias, restenosis, cardiac hypertrophy, autoimmune disorders |
| 05/25/2006 | US20060111373 Pyrazolo [3,4-d] pyrimidine derivatives and their use as purinergic receptor antagonists |
| 05/25/2006 | US20060111372 Alkyl-substituted pyrazolopyrimidines |
| 05/25/2006 | US20060111371 Protein tyrosine kinase inhibitors |
| 05/25/2006 | US20060111370 Use in treatment of cardiovascular diseases, cognitive and neurodegenerative diseases, inhibitors of Human Immunodeficiency Virus, plasmepsins, cathepsin D and protozoal enzymes; 5-(3-(3-trifluoromethoxyphenyl)phenyl)-2,5-dimethyl-1,2,4-oxadiazinan-3-imine, for example |
| 05/25/2006 | US20060111369 Synthesis, characterization and biological action of optically active isomers of floxacins |
| 05/25/2006 | US20060111368 Phosphodiesterase inhibitor |
| 05/25/2006 | US20060111367 Lung cancer, gastric cancer, liver cancer, leucocythemia, endometrioma, oophoroma, mammary cancer, colon cancer, prostatic cancer, or pituitary gland cancer; N (N',N'-dimethylaminoethyl)benzo[b]thieno[2,1-c]naphthalimide |
| 05/25/2006 | US20060111366 Pharmaceutical use of substituted amides |
| 05/25/2006 | US20060111365 Combinations comprising N- {5-[4- [4-methy L-piperazino-methyl) -benzoylamido] -2-methylphenyl) -4- (3-pyridyl) -2-pyrimidine-amine and at least one telomerase inhibitor |
| 05/25/2006 | US20060111364 Reversible inhibitors of cysteine proteases S, K, F, L and B; N-[2-(Benzylamino)pyrimidin-4-yl]-N-(cyanomethyl)-L-phenylalaninamide |
| 05/25/2006 | US20060111363 Treatment of uveal melanoma |
| 05/25/2006 | US20060111362 1,3-Dihydroimidazole ring compound |
| 05/25/2006 | US20060111361 Method of reversing left ventricle remodeling |